Latest Health News

Deep Brain Stimulation Can Reduce Fatigue in Patients with Multiple Sclerosis

Around 90% of multiple sclerosis (MS) patients suffer from fatigue. Fatigue is one of the most troublesome symptoms in MS patients. They have to give up their careers due to fatigue. It can also drastically hamper their social life. There are no licensed pharmaceutical treatments available to cure fatigue in MS patients. Moreover, deep transcranial magnetic stimulation (dTMS) has been long used to treat several psychiatric and neurological disorders.

Dr. Friedemann Paul, professor at the NeuroCure Clinical Research Center (NCRC), Berlin, Germany, led this research. The researchers used a H-coil technology that produces three times the effects of a standard transcranial magnetic stimulation (TMS). This technology provides significant improvements in MS-associated fatigue.

The research included 33 participants. The researchers assessed the severity of the participants’ condition by using a Fatigue Severity Scale (FSS) and a standardized questionnaire. These participants experienced fatigue due to MS. They received three dTMS sessions per week for six weeks. These participants got a H-coil placed over their heads that produced a magnetic field. The neural brain circuits and the nerve activities were influenced by this magnetic field produced by the H-coil. While a control group of participants received a relatively ineffective treatment.

Dr. Paul revealed that there were no major side effects of using this noninvasive magnetic stimulation treatment. The H-coil used in the study was specially designed for this study. This H-coil allows the targeted stimulation of the areas in the brain that are specifically linked with MS related fatigue.

ADVERTISEMENT

The research will be conducted on a larger group of participants very soon. This will allow to test the efficiency of the treatment and will highlight the benefits of dTMS in reducing fatigue symptoms due to Multiple Sclerosis. The research will pave way for implementing dTMS to treat fatigue in MS patients during routine clinical treatment.

Peter D. Griffin

A post graduate in health journalism, Peter is a full-time journalist with a leading health magazine. In the free time, he likes to read and write about medical research, health issues, drug discoveries and related topics.

Recent Posts

All-Natural Formula to Detoxify Your Body and Encourage Weight Loss

Our lives have been dealing with some disastrous happenings due to the global health crisis.…

4 years ago

Can Evolution Be Blamed For High Risk Of Advanced Cancers In Humans?

A study led by researchers at the University of California San Diego School of Medicine…

5 years ago

How The COVID-19 Pandemic Has Impacted the Environment?

Researchers from several research institutes presented their results at the American Geophysical Union's fall meeting.…

5 years ago

Winter Magic Food: Say Goodbye to Health Issues With Jaggery

A lot of us wait for the winters to arrive as it brings relief from…

5 years ago

New Antiviral Drug Might Prevent The Spread of Covid, Research Confirms

While the world is aiming to develop vaccines to control covid-19, researchers at the Institute…

5 years ago

18 Ultimate Foods That Help Lower Blood Pressure

Also known as hypertension, high blood pressure affects large population across the world. Hypertension is…

5 years ago